Clinical trial
A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection
NCT02066428
Study timeline
Study start (unknown)2007-11-01Date precision: month
Registry last updated2014-02-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Tuberculosisunresolved
Interventions
Sponsors & collaborators
Aeraslead sponsor
Statens Serum Institutcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02066428 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.